Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Comment by guerreiroon Dec 08, 2020 2:20am
176 Views
Post# 32055933

RE:RE:RE:Future Value of IPOT

RE:RE:RE:Future Value of IPOTOptions were approved for insiders today at .32 cents. That is possible why they were holding the stock back.


Filing
DateTransaction
DateInsider NameOwnership
TypeSecuritiesNature of transactionVolume or ValuePriceDec 7/20Dec 7/20Bromley, SeanDirect OwnershipOptions50 - Grant of options300,000$0.320
Dec 7/20Dec 7/20Arbel, IritDirect OwnershipOptions50 - Grant of options100,000$0.320
Dec 7/20Dec 7/20Chatterton, MatthewDirect OwnershipOptions50 - Grant of options100,000$0.320
Dec 7/20Dec 7/20Popova, YanaDirect OwnershipOptions50 - Grant of options300,000$0.320
Dec 7/20Dec 7/20Jones, Darryl BakerDirect OwnershipOptions50 - Grant of options300,000$0.320


<< Previous
Bullboard Posts
Next >>